141 related articles for article (PubMed ID: 16125730)
1. Ventricular hypertrophy and arterial hemodynamics following deprivation of nitric oxide in rats.
Hu CT; Chang HR; Hsu YH; Liu CJ; Chen HI
Life Sci; 2005 Nov; 78(2):164-73. PubMed ID: 16125730
[TBL] [Abstract][Full Text] [Related]
2. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of nitric oxide blockade with L-NAME on arterial haemodynamics in the rat.
Hu CT; Chang KC; Wu CY; Chen HI
Br J Pharmacol; 1997 Nov; 122(6):1237-43. PubMed ID: 9401792
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic mechanism of ventricular hypertrophy in hypertension.
Chen HI
Chin J Physiol; 2012 Dec; 55(6):369-79. PubMed ID: 23286444
[TBL] [Abstract][Full Text] [Related]
5. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Hori M; Kitakaze M
J Cardiol; 2003 Jan; 41(1):43-4. PubMed ID: 12564115
[TBL] [Abstract][Full Text] [Related]
6. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
7. [Effect of berberine on left ventricular remodeling in renovascular hypertensive rats].
Zhao HP; Hong Y; Xie JD; Xie XR; Wang J; Fan JB
Yao Xue Xue Bao; 2007 Mar; 42(3):336-41. PubMed ID: 17520837
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension.
Liu YC; Kao SJ; Chuang IC; Chen HI
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1173-80. PubMed ID: 17880373
[TBL] [Abstract][Full Text] [Related]
9. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?
Kopincova J; Puzserova A; Bernatova I
Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608
[TBL] [Abstract][Full Text] [Related]
10. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Bernátová I; Pechánová O; Pelouch V; Simko F
J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
[TBL] [Abstract][Full Text] [Related]
11. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular hypertrophy in rats with biliary cirrhosis.
Inserte J; Perelló A; Agulló L; Ruiz-Meana M; Schlüter KD; Escalona N; Graupera M; Bosch J; Garcia-Dorado D
Hepatology; 2003 Sep; 38(3):589-98. PubMed ID: 12939585
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats.
Zanfolin M; Faro R; Araujo EG; Guaraldo AM; Antunes E; De Nucci G
J Cardiovasc Pharmacol; 2006 Mar; 47(3):391-5. PubMed ID: 16633081
[TBL] [Abstract][Full Text] [Related]
14. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
Rose M; Balakumar P; Singh M
Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis.
McVeigh GE; Allen PB; Morgan DR; Hanratty CG; Silke B
Clin Sci (Lond); 2001 Apr; 100(4):387-93. PubMed ID: 11256976
[TBL] [Abstract][Full Text] [Related]
16. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
17. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
[TBL] [Abstract][Full Text] [Related]
18. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
[TBL] [Abstract][Full Text] [Related]
19. Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.
Gaballa MA; Raya TE; Hoover CA; Goldman S
Cardiovasc Res; 1999 Jun; 42(3):627-35. PubMed ID: 10533602
[TBL] [Abstract][Full Text] [Related]
20. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
